House Appropriators Tip-Toe Into Biologics Transition Controversy

 
• By Derrick Gingery
Capitol House
The US FDA's FY 2020 appropriations bill now moves to the full House of Representatives for consideration. • Source: Shutterstock

More from US FDA

More from Agency Leadership